Virbac: Q3 sales rise 7.8%
(CercleFinance.com) - The animal health group's Q3 sales came in at E314.
8m, up 7.8% at constant exchange rates. At actual exchange rates, sales rose 3.3% y-o-y.
All geographical regions contributed to this dynamic performance, led by Europe, where sales rose by 6.4% at constant exchange rates.
Sales for 9m to end-September came to E925.3m, just up from E921.2m in 9m 2022, i.e. overall growth of +0.4% and +2.8% at constant exchange rates.
LFL growth is now expected to be between 2% and 4%, while the ratio of "operating profit on ordinary activities before amortisation of assets acquired through acquisitions" to "sales" is now expected in a range of between 13.5% and 14.5% at constant exchange rates.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
8m, up 7.8% at constant exchange rates. At actual exchange rates, sales rose 3.3% y-o-y.
All geographical regions contributed to this dynamic performance, led by Europe, where sales rose by 6.4% at constant exchange rates.
Sales for 9m to end-September came to E925.3m, just up from E921.2m in 9m 2022, i.e. overall growth of +0.4% and +2.8% at constant exchange rates.
LFL growth is now expected to be between 2% and 4%, while the ratio of "operating profit on ordinary activities before amortisation of assets acquired through acquisitions" to "sales" is now expected in a range of between 13.5% and 14.5% at constant exchange rates.
Copyright (c) 2023 CercleFinance.com. All rights reserved.